Efficacy of Probiotics Supplementation On Chronic Kidney Disease: a Systematic Review and Meta-Analysis

被引:56
|
作者
Jia, Linpei [1 ]
Jia, Qiang [1 ]
Yang, Jingyan [2 ]
Jia, Rufu [2 ]
Zhang, Hongliang [3 ]
机构
[1] Capital Med Univ, Dept Nephrol, Xuanwu Hosp, Beijing, Peoples R China
[2] Cent Hosp Cangzhou, Cangzhou, Peoples R China
[3] Natl Nat Sci Fdn China, Dept Life Sci, Beijing, Peoples R China
来源
KIDNEY & BLOOD PRESSURE RESEARCH | 2018年 / 43卷 / 05期
关键词
Probiotics; Chronic kidney disease; Uremic toxin; Intestinal microbiota; Randomized controlled trial; P-CRESOL; CARDIOVASCULAR RISK; SYNBIOTIC TREATMENT; GUT MICROBIOTA; RENAL-FAILURE; DOUBLE-BLIND; JAK-STAT; HEALTHY; MICROFLORA; CYTOKINE;
D O I
10.1159/000494677
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Background/Aims: Dysbiosis of the intestinal microbiota may accelerate the progression of chronic kidney disease (CKD) by increasing the levels of urea toxins. In recent years, probiotics have been recognized to maintain the physiological balance of the intestinal microbiota. In this study, we aim to assess the therapeutic effects of probiotics on CKD patients with and without dialysis via meta-analysis. Methods: We conducted a meta-analysis of randomized controlled trials (RCTs) by searching the databases of Pubmed, EMBASE and Cochrane Library (No. CRD42018093080). Studies on probiotics for treatment of CKD adults lasting for at least 4 weeks were selected. The primary outcomes were the levels of urea toxins, and the second outcomes were the levels of interleukin (IL)-6, C-reactive protein (CRP) and hemoglobin (Hb). The risk of bias was assessed by Cochrane Collaboration' tool, and the quality of evidence was appraised with the Grading of Recommendation Assessment. Means and standard deviations were analyzed by random effects analysis. Stratified analysis was done and sensitivity analysis was performed when appropriate. Results: Totally, eight studies with 261 patients at CKD stage 3 to 5 with and without dialysis were included. We found a decrease of p-cresyl sulfate (PCS) of 3 studies with 125 subjects (P = 0.01, SMD-0.57, 95% CI,-0.99 to-0.14, /2 = 25%) and an increase of IL-6 in 3 studies with 134 subjects (P = 0.03, 95% CI, SMD 0.37, 0.03 to 0.72, /2 = 0%) in the probiotics groups. Analysis of serum creatinine (P = 0.47), blood urine nitrogen (P = 0.73), CRP (P = 0.55) and Hb (P = 0.49) yielded insignificant difference. Conclusion: Limited number of studies and small sample size are limitations of our study. Probiotics supplementation may reduce the levels of PCS and elevate the levels of IL-6 whereby protecting the intestinal epithelial barrier of patients with CKD. (C) 2018 The Author(s) Published by S. Karger AG, Basel
引用
收藏
页码:1623 / 1635
页数:13
相关论文
共 50 条
  • [31] Efficacy and safety of ketoanalogue supplementation combined with protein-restricted diets in advanced chronic kidney disease: a systematic review and meta-analysis
    Chen, Chih-Heng
    Tsai, Ping-Hsiu
    Tsai, Wan-Chuan
    Ko, Mei-Ju
    Hsu, Le-Yin
    Chien, Kuo-Liong
    Hung, Kuan-Yu
    Wu, Hon-Yen
    JOURNAL OF NEPHROLOGY, 2024, 37 (08) : 2113 - 2125
  • [32] Chronic kidney disease in inflammatory bowel disease: systematic review and meta-analysis
    Zadora, Ward
    Innocenti, Tommaso
    Verstockt, Bram
    Meijers, Bjorn
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2287 - I2288
  • [33] Chronic kidney disease in inflammatory bowel disease: systematic review and meta-analysis
    Innocenti, T.
    Zadora, W.
    Meijers, B.
    Verstockt, B.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I966 - I967
  • [34] Chronic Kidney Disease in Inflammatory Bowel Disease: a Systematic Review and Meta-analysis
    Zadora, Ward
    Innocenti, Tommaso
    Verstockt, Bram
    Meijers, Bjorn
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (09): : 1464 - 1475
  • [35] Chronic kidney disease in inflammatory bowel disease: systematic review and meta-analysis
    Zadora, Ward
    Innocenti, Tommaso
    Verstockt, Bram
    Meijers, Bjorn
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [36] Chronic Kidney Disease and Cognitive Impairment: A Systematic Review and Meta-Analysis
    Etgen, Thorleif
    Chonchol, Michel
    Foerstl, Hans
    Sander, Dirk
    AMERICAN JOURNAL OF NEPHROLOGY, 2012, 35 (05) : 474 - 482
  • [37] CHRONIC KIDNEY DISEASE AND RISK OF STROKE: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Philip, Masson
    Martin, Huong
    Robin, Turner
    Richard, Lindley
    Jonathan, Craig
    Angela, Webster
    NEPHROLOGY, 2014, 19 : 63 - 63
  • [38] Chronic kidney disease and postoperative mortality: A systematic review and meta-analysis
    Mathew, A.
    Devereaux, P. J.
    O'Hare, A.
    Tonelli, M.
    Thiessen-Philbrook, H.
    Nevis, I. F. P.
    Iansavichus, A. V.
    Garg, A. X.
    KIDNEY INTERNATIONAL, 2008, 73 (09) : 1069 - 1081
  • [39] CHRONIC KIDNEY DISEASE AND RISK OF STROKE: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Masson, P.
    Hong, M.
    Turner, R.
    Lindley, R.
    Webster, A.
    Craig, J.
    NEPHROLOGY, 2013, 18 : 31 - 31
  • [40] Pentoxifylline for Anemia in Chronic Kidney Disease: A Systematic Review and Meta-Analysis
    Bolignano, Davide
    D'Arrigo, Graziella
    Pisano, Anna
    Coppolino, Giuseppe
    PLOS ONE, 2015, 10 (08):